SOURCE: BioCentury Publications

March 27, 2008 07:00 ET

BioCentury Launches Major Upgrade to BCIQ: BioCentury Online Intelligence

BioPharma Data Warehouse Now Provides Stock Performance and Financial Statement Data to Complement Up-to-Date Intelligence on Companies, Product Pipelines and Financings

NEW YORK, NY--(Marketwire - March 27, 2008) - BioCentury Publications, Inc., the leading provider of independent, informed bio-industry business intelligence, announced today the launch of BCIQ 2.0, a major upgrade to the company's powerful BCIQ: BioCentury Online Intelligence data service.

The company announced the new development in association with the Future Leaders in the Biotech Industry Conference taking place today in New York City. The enhanced service now provides stock price and financial performance data in addition to the currently available intelligence on more than 4,000 companies, 5,000 biopharma products and $200 billion in financings. BCIQ 2.0 also supplies improved management tools for each user to personalize and save specific searches and reports.

"For the past 15 years, the BioCentury editorial team has relied upon our own meticulously maintained data for the accurate biopharma information that industry insiders have come to expect in all of our publications," said BioCentury Publisher Eric Pierce. "Our authoritative, trustworthy database has become even more valuable with the expanded Financial Analyst module, which now includes more detailed fiscal data on public and private biotechnology and pharmaceutical companies."

Fully Integrated Modules -- BCIQ subscribers are able to access comprehensive industry information via a single application that drives all searches and is powered with continuously updated, reliable data from BioCentury's team of researchers, analysts and industry experts. The database comprises three fully integrated, relational modules:

--  Financial Analyst:  Allows users to filter and download data on more
    than 7,000 public and private financing transactions totaling more than
    $200 billion, and to compare companies on key financial statement and stock
    performance benchmarks.
    
--  Company Analyst:  Provides subscribers with access to data on more
    than 4,000 public and private companies for which subscribers can build and
    track peer groups based on individual areas of interest.
    
--  Pipeline Analyst: Uses a multitude of search criteria to analyze
    metrics and milestones on more than 5,000 products in active development or
    on the market in approximately 500 indications.
    

Built-In Access to BioCentury Archives -- This fully integrated platform also includes direct links to the more than 120,000 articles, charts, figures and analysis contained in the complete BioCentury Archives, which is included with each BCIQ subscription.

"BCIQ 2.0 adds significant value by providing cleaner data, better filters and improved financial detail that will ultimately help empower biopharma companies and their financial partners to make highly educated business and investment decisions," said Mr. Pierce.

For information on how to subscribe to this authoritative database or to see if you qualify for a free trial, contact BioCentury at +1 650-595-5333 or e-mail BCIQ@biocentury.com.

About BioCentury

BioCentury Publications, Inc., is an independently owned and operated company based in Redwood City, Calif., that provides essential biopharma industry intelligence from five offices in the U.S. and Europe. Over the past 15 years, a global audience of biotech and pharmaceutical executives and investors has benefited from BioCentury's deep knowledge, data-driven analysis, independent perspective and trustworthy content provided by the company's publications, including BioCentury, the Bernstein Report on BioBusiness and SciBX: Science-Business eXchange, as well as its BCIQ: BioCentury Online Intelligence database, which contains more than 4,000 companies, 5,000 compounds and $200 billion in financing transactions, and through BioCentury's collaborative industry conferences in the U.S., Europe and Asia. For more information, visit www.biocentury.com.

BioCentury®; The Bernstein Report on BioBusiness®; The BioCentury 100™; The Clear Route to ROI™, Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™, and SciBX™ are trademarks of BIOCENTURY PUBLICATIONS, INC. Copyright © 2008. ALL RIGHTS RESERVED.

Contact Information

  • Media Inquiries Contact:
    Lana Guernsey
    WeissComm Partners
    1-415-946-1073 office
    Email Contact

    Stacie D. Byars
    WeissComm Partners
    1-415-946-1072 office
    Email Contact